Conventional-dose chemotherapy compared with high-dose chemotherapy plus autologous hematopoietic stem-cell transplantation for metastatic breast cancer. Philadelphia Bone Marrow Transplant Group

scientific article

Conventional-dose chemotherapy compared with high-dose chemotherapy plus autologous hematopoietic stem-cell transplantation for metastatic breast cancer. Philadelphia Bone Marrow Transplant Group is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1056/NEJM200004133421501
P698PubMed publication ID10760307

P50authorEdward A. StadtmauerQ85544110
P2093author name stringLazarus HM
O'Neill A
Mangan KF
Brodsky I
Glick JH
Ingle JN
Martino S
Goldstein LJ
Erban JK
Crilley PA
Sickles C
P2860cites workHigh-dose chemotherapy with hematopoietic rescue as primary treatment for metastatic breast cancer: a randomized trialQ34298656
P433issue15
P407language of work or nameEnglishQ1860
P921main subjectbone marrowQ546523
chemotherapyQ974135
stem cell transplantationQ65592366
metastatic breast cancerQ12859063
P304page(s)1069-1076
P577publication date2000-04-01
P1433published inThe New England Journal of MedicineQ582728
P1476titleConventional-dose chemotherapy compared with high-dose chemotherapy plus autologous hematopoietic stem-cell transplantation for metastatic breast cancer. Philadelphia Bone Marrow Transplant Group
P478volume342

Reverse Query: null

Search more.